Loading...
Johnson & Johnson
JNJ•NYSE
HealthcareDrug Manufacturers - General
$154.53
$-0.40(-0.25%)
Johnson & Johnson (JNJ) AI-Powered Stock Analysis
See how Johnson & Johnson scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerJohnson & Johnson (JNJ) Stock Overall Grade
Johnson & Johnson’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B+
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Johnson & Johnson's overall stock rating.
Forecast
A+Score
100/100Financial Growth
BScore
65/100Fundamental Growth
AScore
83/100Key Ratios
B+Score
77/100Sector Comparison
B+Score
75/100Industry Comparison
A+Score
90/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
59/100Component Analysis Explained
Understand the key factors behind each Johnson & Johnson stock grade, including financials, comparisons, and forecasts.